Navratri is just around the corner, and it’s time to get ready for those vibrant Garba nights. This nine-day festival is all about colorful outfits, delicious food, and, of course, dancing to the beat ...

The sibling duo’s follow-up EP spikes their off-kilter pop with new darkness, adding atmospheric balladry to their glorious racket From South London Recommended if you like Charli xcx, Confidence Man, ...

At age 19, JC Btaiche, the son of a nuclear physicist, decided not to pursue a college degree. Since he was a young boy, he was fascinated by the physics of the cosmos and, eventually, nuclear fusion, ...

Fusion power has always been a bit of a contradiction. The fusion part is actually kind of easy — an undergrad recently built a simple fusion device in his bedroom, for example — but getting ...

The Bengaluru-based startup is planning to deploy the freshly raised capital to strengthen its R&D Pranos Fusion is a Bengaluru-based deeptech startup developing nuclear fusion technology using ...

Germany has become a surprising dark horse in the race for commercial nuclear fusion by committing €1.7 billion in funding to build the world's first commercial fusion reactor. German company Proxima ...

The Kalen DeBoer era for Alabama football is in full swing, and while the roster gets most of the attention, the coaching staff is quietly becoming one of the most intriguing groups in the country.

Michael Anthony weighed in on the upcoming Van Halen project that Alex Van Halen has been teasing—and he shared some advice to his former bandmate. Amid rumors that an upcoming album will feature ...

KALAMAZOO, Mich. — A stretch of harsh winter weather has pushed many West Michigan school districts closer to the limit on snow days, prompting administrators to closely monitor calendars and plan for ...

⚠️ This page mixes confirmed information with industry rumors and speculation. We’ll keep it updated as new details and leaks come to light. Ready to go gambling once again? Hellishly fun gambling ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion buyout of Immunomedics in 2020. But ...